Article
Biomarkers and therapeutic advances in glioblastoma multiforme
25 Aug 2017
Abstract excerpt
Abstract Glioblastoma multiforme (GBM) is a malignant tumor within the brain. Generally classified as primary and secondary with several different subtypes, ample molecular biomarkers have risen throughout the years which have garnered the attention of researchers. The advancements in genomics and proteomics have allowed researchers to gather prominent molecular biomarkers. All these biomarkers are gathered by...
Topics
Join the communities discussing this publication.